bpc-157 news 2025 october fda warning FDA's Overreach on Compounded Peptides BPC-157 and the Difference Between – Sample of patents with BPC

Persistent neurological symptoms, fatigue, or symptom recurrence before scheduled injections warrant medical review and possible dosage adjustment

State Lyophilized (powder) Storage -4F (-20C) long-term Notes Per supplier safety data sheets, the lyophilized peptide is stable for one year or more under freezer storage

Because AOD 9604 has not completed the full clinical development pathway, its comprehensive side-effect profile in humans is not well characterised and should not be assumed to be benign

Gou, Y., et al

Li S, Jansone-Popova S, Jiang DE (2024) Insights into coordination and ligand trends of lanthanide complexes from the Cambridge Structural Database